takeout smith nephew
friday post-clos financi time report smith nephew
snn rate talk acquir buy pt
articl specul ft histori
postul med-tech prove fals
buy buy pt analyst lavin
syk-snn multipl occas want explor strateg
consider potenti take-out spoke briefli
management late friday even expect management say much
market valu would nuva close price friday
also far cri share trade less month ago
ultim definit view whether take-out
occur see potenti much feasibl paper
necessarili slam-dunk snn perspect nuva given
recent chang management product cycl current valuat among
reason discuss consider
snn perspect item consid snn
commentari suggest interest activ snn
less activ past year snn tone chang
compani hire new ceo namal nawana april mr
nawana state snn financi capac net debt/ebitda
ebitda would like
adjac market good strateg fit help snn grow
mr nawana also ran depuy synth spine johnson johnson
rate previous suggest familiar spine space
product perspect littl overlap sale
distribut stabil could prove challeng snn portfolio
trauma deform pediatr product would pair well
nuva activ grow rod technolog pediatr scoliosi limb
length discrep beyond snn spinal
implant portfolio challeng perspect seen
spine deal maintain distribut mani histor spine
deal challeng sale rep look opportun
higher commiss rate compani acquir given
articl broke deal consumm would suggest
view rep retent could becom bigger challeng
come week month snn proce acquisit
discuss consider nuva perspect
pleas read import disclosur analyst certif appear appendix
nuva new ceo start less month ago recal ceo
chri barri left buy pt analyst lavin
helm ceo mr barri background robot fit nice
nuva push spinal robot futur direct
compani would odd us someon would consid role
compani realli go sell soon began
especi major product initi underway puls
could unlock sharehold valu
realli growth asset today snn state want
acquir growth asset ultim improv compani profil
abl grow top-lin msd doesnt appear
us would add kind growth snn may
look consid type bolt-on acquisit
compani undertaken past
success acquisit significantli smaller market
cap revenu perspect significantli higher growth
nuva entellu novadaq hyperbranch etc
would note snn acquisit ceterix first
follow pattern front potenti valu
uniqu asset acquisit would requir snn retain
entir sale organ note
challeng may even dampen potenti cost synergi given
nuva service-ori busi segment stand
nuva gross margin adjust oper margin dilut
snn current gross margin adjust oper margin
snn would pick ntm ev/sal
fair deal snn in-lin nuva histor averag
past year would note alleg offer would give
sharehold signific premium friday close price
multipl perspect would essenti line
compani histor multipl averag account
strateg growth driver mention upsid
margin on-going cost measur find unlik
sharehold would find offer histor averag multipl
adequ
impact potenti deal snn balanc sheet oper
neglig lastli would ask whether snn sharehold
happi deal natur nuva price may attract
snn perspect acquisit would significantli chang
composit snn would requir snn lever
debt deal dilut margin snn share trade
dollar post-clos friday follow news
btig cover compani mention report
appendix analyst certif import disclosur
ryan zimmerman herebi certifi view compani secur discuss report
accur express receiv receiv direct indirect compens exchang
express specif recommend view report
samuel brodovski herebi certifi view compani secur discuss report
accur express receiv receiv direct indirect compens exchang
express specif recommend view report
btig llc btig rate effect june defin follow
buy secur expect produc posit total return greater month
follow recommend buy rate may maintain long deem appropri
notwithstand price fluctuat would caus target fall outsid return
sell secur expect produc neg total return greater next month
follow recommend sell rate may maintain long deem appropri
notwithstand price fluctuat would caus target fall outsid return
neutral secur expect appreci depreci meaning next month
rate secur rate cover btig
review effect immedi coverag follow secur review rate price
target disclosur estim compani list suspend longer reli
